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ABSTRACT
Melanoma cells steer out of tumours using self-generated
lysophosphatidic acid (LPA) gradients. The cells break down LPA,
which is present at high levels around the tumours, creating a dynamic
gradient that is low in the tumour and high outside. They then migrate
up this gradient, creating a complex and evolving outward chemotactic
stimulus. Here, we introduce a new assay for self-generated
chemotaxis, and show that raising LPA levels causes a delay in
migration rather than loss of chemotactic efficiency. Knockdown of the
lipid phosphatase LPP3 – but not of its homologues LPP1 or LPP2 –
diminishes the cell’s ability to break down LPA. This is specific for
chemotactically active LPAs, such as the 18:1 and 20:4 species.
Inhibition of autotaxin-mediated LPA production does not diminish
outward chemotaxis, but loss of LPP3-mediated LPA breakdown
blocks it. Similarly, in both 2D and 3D invasion assays, knockdown of
LPP3 diminishes the ability of melanoma cells to invade. Our results
demonstrate that LPP3 is the key enzyme in the breakdown of LPA by
melanomacells, and confirm the importance of attractant breakdown in
LPA-mediated cell steering.
This article has an associated First Person interview with the first
author of the paper.
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INTRODUCTION
Malignant melanoma is the most aggressive form of skin cancer,
accounting for the majority of skin cancer-related deaths (American
Cancer Society, 2014). Melanoma is highly treatable if diagnosed in
its early stages while still localized; however, patient prognosis
worsens significantly once metastasis has occurred. Melanoma
is often classified according to its localization and growth
characteristics, transitioning from early ‘radial growth phase’
(RGP) plaques localized in the epidermis, to proliferative ‘vertical
growth phase’ (VGP) tumours that can break through the basement
membrane into the dermis, increasing the likelihood of metastasis
(Bennett, 2008; Elder, 2015). The factors involved in bringing about
melanoma metastasis are still not completely understood. Changes
in cell–cell adhesion due to alterations in cadherin expression, and
other changes in the gene expression programme related to
epithelial–mesenchymal transition (EMT), may play a part by
altering the cytoskeletal, invasive and migratory properties of cells
and weakening cell–cell junctions (Li et al., 2015). However, in the
case of melanoma, other drivers of metastasis are thought to be
particularly important. One such driver is chemotaxis, in which cells
migrate up gradients of extracellular signals. However, the signals
driving melanoma cell migration out of the primary tumour are
poorly characterized. One signal that may contribute to melanoma
metastasis is the phospholipid signalling molecule lysophosphatidic
acid (LPA), which was recently discovered to be a strong
chemoattractant for melanoma cells (Muinonen-Martin et al., 2014).
LPA has been implicated in a wide range of signalling pathways
and cellular processes including proliferation, migration, survival
and adhesion. It consists of a phosphate head group, glycerol
backbone and acyl chain of varied length and saturation,
characteristics that control biological activity (Jalink et al., 1995).
Longer acyl chains and, in particular, unsaturated C:C bonds within
the acyl group correlate with greater activity; short acyl chains and
complete saturation make the LPA almost inactive (Jalink et al.,
1995). The 18:1, 18:2 and 20:4 species (18 or 20 carbons in the acyl
chain and one, two or four unsaturated bonds) are thought to be the
most active in vivo. LPA is found both intracellularly and
extracellularly in tissues, and is also a major component of serum
(Eichholtz et al., 1993; Baker et al., 2001; Yung et al., 2014).
Extracellular LPA may be generated from lysophosphatidylcholine
(LPC) via autotaxin, or converted from phosphatidic acid by
membrane-bound phospholipase A1. However, source–sink
gradients, in which one cell type produces LPA and another
removes it to set up a chemotactic gradient, have not been found.
LPA mediates its effects through a family of seven
transmembrane G-protein-coupled receptors. Six LPA receptors
have been identified (LPAR1–LPAR6), which bind LPA with
varying affinity and interact with different combinations of the four
Gα proteins: Gα12/13, Gαq/11, Gαi/o or Gαs (Pasternack et al., 2008;
Yung et al., 2014). LPA is broken down by a family of lipid
phosphate phosphatases (LPPs). The LPPs are transmembrane
enzymes located at the plasma membrane with an extracellular
active site, and also on intracellular membranes. They
dephosphorylate LPA into biologically inactive monoacylglycerol
(MAG). There are three known mammalian LPPs (LPP1–LPP3;
also known as PPAP2A, PPAP2C and PPAP2B, respectively) and
an additional splice variant of LPP1 (Samadi et al., 2011).Received 21 June 2017; Accepted 18 August 2017
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LPA degradation by melanoma cells is of particular interest, as
they appear to be able to form gradients with a low LPA
concentration within the tumour and high LPA outside it
(Muinonen-Martin et al., 2014), thus setting up a ‘self-generated’
gradient directing cells outwards from the primary tumour (Tweedy
et al., 2016b). Although LPA is a well-known inducer of cell
motility and the role of LPA signalling in ovarian cancer is well
studied (Fang et al., 2002; Tanyi et al., 2003a), it has only recently
been shown to be a uniquely powerful chemoattractant for
melanoma cells (Muinonen-Martin et al., 2014). Thus LPA
gradients could facilitate the exit and metastasis of melanoma
cells from the tumour. Here, we investigated the mechanism by
which melanoma cells break down LPA, demonstrating that LPP3 is
crucial for the formation of self-generated LPA gradients and
subsequent chemotaxis and invasion.
RESULTS
Melanoma cells respond least efficiently to high
concentrations of LPA
LPA is found in serum at varying concentrations of 0.1–10 μM
(Eichholtz et al., 1993; Xu et al., 1998; Baker et al., 2001; Fang
et al., 2002; Mazzocca et al., 2011; Yung et al., 2014), with an
average of ∼1 μM, although this has been shown to increase under
pathological conditions including various cancers. In contrast, the Kd
of LPAR1, the most important LPA receptor, is ∼10 nM (Choi et al.,
2010). The concentration of LPA in serum – or even the 10% serum
used in culture medium – is therefore saturating to most sensitive cells.
As a significant difference in receptor occupancy across cells is
required for directed chemotaxis, we investigated howmelanoma cells
are able to sense and respond to these high concentrations of LPA.
To test the response ofmelanoma cells to increasing concentrations
of LPA, we used Insall chambers (Muinonen-Martin et al., 2013,
2014) to visualize chemotaxis, in particular measuring evolution of
chemotactic efficiency over time. The use of direct-viewing chambers
allowed us to quantify chemotaxis in detail while cells migrated. One
straightforward output is the chemotactic index, described by the
cosine of the angle between the gradient and the cells’migration (cos
θ); positive chemotactic indices indicatemigration up-gradient, with a
value of >0.1 indicating significant chemotaxis.
When imposing an external chemotactic gradient across the cells,
we found that increasing concentrations of LPA did not increase the
efficiency of directional migration of WM239A metastatic
melanoma cells (Fig. 1). Although the WM239A cells were able
to migrate towards LPA at all concentrations between 100 nM and
10 μM, (Fig. 1A), the efficiency of chemotaxis evolved differently
as the concentration rose. With an initial concentration of 100 nM
LPA, cells were immediately chemotactic (Fig. 1Bi), with a mean
chemotactic index of 0.22 (±0.06 s.e.m.) (Fig. 1Bii). This dropped
over time, most likely reflecting the degradation of LPA. When
using 1 μM LPA, the initial level of chemotaxis was slightly lower
(0.18±0.2) (Fig. 1Bi), but increased to 0.23±0.3 by 18–24 h. In
contrast, at high concentrations of LPA (10 μM), chemotaxis was
initially negligible, increasing over 24 h. Cells never reached the
same chemotactic index as at lower concentrations of LPA. These
results support the hypothesis that cells’ receptors are saturated at
high concentrations of LPA, making it impossible for cells to
perceive local changes, but they eventually break down LPA to
sub-saturating levels that allow them to sense a gradient.
It is not currently technically possible to measure dynamic spatial
LPA gradients directly. We therefore used a mathematical model
that accurately represents the way cells modify gradients while
responding to them (Tweedy et al., 2016a) to further assess
melanoma cell responses to varying levels of LPA. Figure 1C shows
such a simulation of cells in different LPA gradients. At low initial
LPA concentrations (0–100 nM), most cells at the front respond at
first as they are experiencing the steepest resolvable LPA gradient,
but behind this front there is very little LPA present for cells to
respond to. Over time, the cells at the front also stop chemotaxing as
the LPA is locally degraded. At intermediate concentrations
(0–1 μM), cells at the front are totally saturated and few initially
respond. However, chemotaxis increases as the LPA is degraded to a
level that cells can respond to. At the highest concentrations
(0–10 μM), chemotaxis only starts once the majority of LPA is
broken down, which takes at least 12 h; even after this time, receptor
saturation limits the ability of cells to perceive a gradient.
Measurement of the chemotactic index of these simulated cells
over time (Fig. S1) demonstrates the close agreement between
model and measured data. This supports our hypothesis that
changes in chemotaxis over time are mediated by the melanoma
cells breaking down LPA as they respond to it.
LPP3 is required for LPA breakdown by melanoma cells
Having demonstrated that the saturating LPA found in serum must
be broken down in order to stimulate melanoma cell chemotaxis, we
determined which enzymes from melanoma cells degrade LPA. We
used siRNA to knock down expression of genes encoding each
relevant mammalian LPP: LPP1, LPP2 and LPP3. Robust and
specific knockdown was obtained in WM239A melanoma cells
(Fig. 2Ai). Next, LPA-containing medium was incubated for 24 h
with WM239A cells, which were untreated or transfected with
either a scrambled non-targeting siRNA or siRNAs targeting one
LPP gene. The medium was analysed by mass spectrometry for LPA
content, with the synthetic 17:0 form added during processing as an
internal control. There was no significant difference between the
different conditions in degradation of the less biologically active 18:0
form of LPA (Fig. 2Aii). However, LPP3 knockdown resulted in
significantly higher levels of 18:1 and 20:4 LPAs (Fig. 2Aii), which
are the biologically active forms responsible for signalling (Jalink
et al., 1995). Over 60 h, we found a clear delay in the rate of 18:1 and
20:4 LPA degradation when LPP3 was knocked down (Fig. 2B).
A slight initial increase in 18:1 and 20:4 LPA at earlier time points
suggests there is a background level of LPA production that is
eventually normally compensated for by LPP3-mediated LPA
breakdown. The addition of the autotaxin inhibitor HA130 leads to
decreased LPA levels after 24 h (Fig. S2), confirming that autotaxin
can mediate further production of LPA over the saturating initial level.
Together, these results demonstrate that LPP3 is the key enzyme for
degradation of the biologically active forms of LPA inmelanoma cells.
An assay to determine the role of LPA breakdown in self-
generated chemotaxis
To investigate self-generated chemotaxis of melanoma cells towards
LPA, we adapted the Insall chamber chemotaxis assay (Muinonen-
Martin et al., 2013) (Fig. 3Ai). Rather than imposing a gradient by
adding serum-free and serum-containing medium to opposite wells,
we added serum-containing medium to both, to create an initially
uniform environment. As the viewing bridge is only 20 µm high, the
local volume of liquid is restricted, and the absolute amount of LPA
is very small. However, the wells are far deeper, and thus contain a
larger reservoir of LPA, which is consequently depleted much more
slowly. Thus local degradation of LPA by cells on the bridge would
be expected to create a double outward-facing gradient, where
cells would be attracted to LPA diffusing from the nearest well
(Fig. 3Aii). As predicted, in this assay cells initially positioned on
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Fig. 1. See next page for legend.
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the left side of the bridge (designated the ‘left cluster’) generally
moved further to the left (Fig. 3Bi–iii) and cells on the right (‘right
cluster’) moved rightwards (Fig. 3Biv–vi, Movie 1). This effect was
significant for both clusters (Rayleigh test for directionality;
P<10−9) (Fig. 3Bi,iv). Furthermore, directionality of cells in both
clusters increased over time, from a slightly positive (rightwards)
initial value to a substantial chemotactic index after 6 h for the right
cluster (Fig. 3Bvi), and corresponding negative (leftwards) values
for the left cluster (Fig. 3Biii). We hypothesized that this delay was
due to the time taken to break down LPA and create a gradient.
To confirm that this effect was specific to LPA, and not a random
effect reflecting the proximity of cells to the edge of the bridge, we
tested the movement of cells in uniform serum-free conditions
(Fig. 3C, Movie 2) and in a uniform serum-containing environment
containing the LPA receptor antagonist Ki16425 (Fig. 3D,
Movie 3). In both cases, we observed no significant directional
movement of cells in either cluster.
LPP3 knockdown inhibits LPA breakdown-mediated
chemotaxis
This assay was used to demonstrate that inhibiting LPA breakdown
by LPP3 knockdown prevents the formation of outward-facing
gradients, and thus prevents self-generated chemotaxis. We used
siRNA to transiently knock down LPP3 expression, using two
individual oligos that consistently reduced LPP3 expression relative
to scrambled controls (Fig. S3). Firstly we demonstrated that LPP3
knockdown itself did not affect the response of melanoma cells to
LPA in an external serum gradient (Fig. 4A). LPP3 siRNA-treated
Fig. 1. Higher LPA concentrations delay melanoma cell chemotaxis.
(A) Representative spider plots showing cell tracks of WM239A metastatic
melanoma cells moving from serum-free media (on the left) towards 100 nM,
1 μM or 10 μM 18:1 LPA (on the right) in an Insall chemotaxis chamber. Axis
scale is in micrometres. (B) Chemotactic response of WM239A cells over time,
in the presence of increasing LPA concentration gradients. Themean (±s.e.m.)
chemotactic index of cells is shown (i) over 24 h and (ii) across 6 h time
increments (n>100 cells for each condition, three independent experiments).
(C) Representative snapshots over time from amathematical model simulating
cells locally degrading and responding to different concentrations of a freely
diffusing chemoattractant (with similar kinetics and receptor affinities to LPA/
LPAR). The red background represents the LPA concentration within the
gradient and corresponding level of LPAR saturation. Solid red indicates a
concentration of 1 μM LPA or higher, and thus high receptor saturation. The
colour fades linearly towhite, which indicates a concentration of 0 μMLPA, and
thus no receptor saturation. Circles in dark blue represent cells able to perceive
the LPA gradient, while circles fading to white represent cells increasingly
unable to perceive the LPA gradient, either because no LPA is present or
because too much LPA is present, oversaturating their receptors.
Fig. 2. LPP3 is required for LPA breakdown by melanoma cells. (A) siRNA knockdown of the LPA breakdown enzymes LPP1, LPP2, LPP3 or a scrambled
control, in WM239A melanoma cells; (i) representative qPCR confirming knockdown of gene expression; (ii) mass spectrometry quantifying relative LPA
content in media cultured for 24 h with WM239A cells. Different forms of LPA are shown: (top to bottom) 18:0, 18:1 and 20:4 (n=4, *P≤0.05 for LPP3 versus all
other conditions, one-way ANOVA). (B) Time course of LPA breakdown by WM239A cells either untreated or treated with control siRNA or siRNA targeting
LPP3 alone (n=4, *P≤0.05; **P<0.01 for untreated versus PPAP2B, two-way ANOVA comparing the area under the curve).
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Fig. 3. See next page for legend.
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cells and scrambled-siRNA controls had similar mean chemotactic
indices (0.195 and 0.15, respectively; Fig. 4Ai), and both
populations showed highly directed migration towards serum with
Rayleigh P-values of <10−10 (Fig. 4Aii). However, in the self-
generated chemotaxis assay, LPP3 knockdown cells displayed
obviously different behaviour from controls. Control cells produced
gradients that triggered chemotaxis of left and right clusters in
opposite directions (Fig. 4Bi). In contrast, LPP3 knockdown caused
a significant reduction in chemotaxis of both clusters, with virtually
no directional migration (P<0.05; Fig. 4Bii, Movie 4). This was
confirmed using the second independent siRNA targeting LPP3
(P<0.01; Fig. 4Biii).
If LPA production via autotaxin was important in cell steering,
we would expect the opposite results to what we observe. Wherever
cell density was high, we would expect to see more LPA and
therefore an attractive stimulus, so cells would tend to aggregate
rather than dispersing outwards. However, as autotaxin is widely
described as a promoter of metastasis, we directly tested its effects.
We performed the assay for cell dispersal in the presence of the
autotaxin inhibitor HA130 (Fig. 4C, Movie 5). Inhibition of
autotaxin did not inhibit differential chemotaxis of melanoma cells
in this assay; if anything the inhibition of background LPA
production enhanced chemotaxis in response to self-generated
gradients. This demonstrates that degradation, rather than
production of the chemoattractant LPA, is the key process
required for production of self-generated gradients and subsequent
cell migration.
LPP3, LPA and 3D invasion
We also investigated if melanoma cell invasion involved self-
generated gradients, and whether LPP3 was required to generate
them. First we used circular invasion assays (CIAs). The CIA
enables direct visualization of cell migration in a manner similar to
direct-view chambers, but in a setting that mimics invasion into 3D
extracellular matrix, by forcing the cells to invade Matrigel (Yu and
Machesky, 2012). We used a different metastatic melanoma cell
line, WM1158, as it displayed higher baseline levels of invasion.
We observed that LPP3 knockdown resulted in reduced levels of
invasion compared with controls (P<0.01; Fig. 5A; Movie 6). As
described earlier, this implies that outward-facing gradients of LPA
are more important than the LPA concentration itself, and that LPP3
is instrumental in forming them.
LPP3 has been reported to be important for cell–cell adhesion and
extracellular matrix modulation by endothelial cells (Humtsoe et al.,
2010). To verify that the reduction in melanoma cell invasion we
measured was due to LPA gradient formation being blocked and not
due to other LPP3-mediated interactions, we tested whether
blocking LPA signalling specifically would inhibit invasion as
well. Treatment of cells before and during the assay with Ki16425
produced a similar effect, markedly inhibiting invasion compared
with controls (P<0.0001; Fig. 5B; Movie 7). In contrast, addition of
the autotaxin inhibitor had no effect on melanoma cell invasion into
the matrix (Fig. 5C; Movie 8). Thus, the formation of self-generated
LPA gradients by LPP3 appears to be a key factor in the chemotaxis
and invasion of melanoma cells.
Finally, we also examined spheroids to determine if LPP3
expression and self-generated gradients were important for invasion
in a 3D assay. We used the metastatic melanoma cell line WM852,
which was the most clearly invasive line available in spheroid
assays, treated with siRNAs targeting LPP3 or scrambled controls.
Spheroids were imaged for 6 days following the addition of the
invasion matrix, with the control spheroids producing many
invasive protrusions outwards from the centre and displaying
eventual dispersal of the cells from the central mass (Fig. 6A). In
comparison, the LPP3 knockdown spheroids displayed reduced
invasion (Fig. 6B). Although LPP3 siRNA knockdown was only
transient and the effect dissipated by day 6 (Fig. 6C), the effect was
still potent enough to shorten and reduce the number of protrusions
being generated, in addition to blocking cell dispersal outwards
from the spheroid. Differences in proliferation appeared to have a
minimal effect, as in the absence of invasion matrix the control
spheroids were only slightly larger than the LPP3 knockdown
spheroids (Fig. 6D).
Overall, these results show that LPA is important in multiple
assays for melanoma cell migration and invasion, and LPP3 plays a
key part in these responses by shaping externally provided LPA into
chemotactic gradients that steer individual cells away from any area
with a high density of cells.
DISCUSSION
We have previously demonstrated the efficiency of self-generated
gradients as a driver of cell migration (Tweedy et al., 2016a) and that
self-generated LPA gradients are key factors in melanoma cell
chemotaxis and thus metastasis (Muinonen-Martin et al., 2014).
Here, we have delineated the mechanism by which melanoma cells
may be triggered to migrate away from the tumour via self-generated
gradients.
LPA is ubiquitous in serum, and also found in healthy tissues.
Serum LPA is often present at a high base concentration of 1 μM
(and significantly higher in some cancers). At this concentration,
receptors at the front and rear of cells are all saturated, so cells are
unable to detect LPA gradients and trigger chemotaxis. In order to
read the gradient, cells need time to degrade the LPA to a level that
does not saturate the LPA receptors, so that they can perceive spatial
variations in LPA concentration as local differences in receptor
occupancy. The higher the LPA concentration, the longer before the
cells can respond. Similarly, the more cells available to degrade the
LPA, the better they are able to respond (Muinonen-Martin et al.,
2014). Our data demonstrate that LPP3 is the key enzyme required
for melanoma LPA breakdown. Furthermore, we have shown
using various different metastatic melanoma cell lines in a range of
2D and 3D assays that LPP3 is essential for the production of a
self-generated LPA gradient that can stimulate melanoma cell
chemotaxis and invasion.
LPP3 plays a non-redundant role in LPA breakdown
Although all three LPPs are thought to have similar catalytic
activity, they appear to have non-redundant functions, as evidenced
by the different phenotypes observed in Ppap2a (LPP1), Ppap2b
(LPP3) and Ppap2c (LPP2) knockout mice. While Ppap2a and
Fig. 3. Spread assay to assess LPA breakdown and chemotaxis.
(A) (i) Side view of an Insall chemotaxis chamber showing inner and outer wells
and positioning of the coverslip with cells adhered to it (adapted from Susanto
et al., 2016); (ii) bird’s eye view of an Insall chamber, indicating the position of
the viewing bridges (in yellow). (B) A uniform serum environment produces
differential directional movement of the cells on the left (left cluster; i–iii) and
right (right cluster; iv–vi) of the bridge, as quantified by mean (±s.e.m.)
chemotactic index (iii, vi) or shown in representative rose plots with Rayleigh
tests for directionality (i, iv) and the corresponding spider plots (ii, v) (n>100
cells per experiment, three independent experiments). In conditions where
there is a uniform serum-free (SF) environment (C) or uniform serum with the
addition of 10 μM Ki16425 (D) there is no significant difference in cell
directionality between the left and right clusters (n>100 cells per experiment,
two to three independent experiments).
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Fig. 4. LPP3 knockdown inhibits
chemotaxis in uniform serum.
(A) LPP3 knockdown (LPP3 siRNA 1)
does not inhibit chemotaxis of
melanoma cells in the presence of a
serum gradient, as assessed by (i)
chemotactic index or (ii) rose plot and
spider plot (n>100 cells per experiment,
two independent experiments).
(B) LPP3 knockdown inhibits differential
chemotaxis of melanoma cells in a
uniform serum gradient, as shown when
comparing (i) scrambled siRNA controls
against cells targeted with two different
siRNAs against LPP3 (ii, iii) (n>100
cells per experiment, four independent
experiments; P<0.05 comparing
clusters 1 and 2 of scrambled versus
LPP3 siRNA 1 and 2, one-way ANOVA).
(C) Chemotaxis of melanoma cells in a
uniform serum gradient in the presence
of either DMSO or 500 nM HA130 to
inhibit autotaxin function, or in a uniform
serum-free (SF) gradient (n>100 cells
per experiment, three independent
experiments).
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Ppap2c knockout mice display only very mild phenotypes (Zhang
et al., 2000; Tomsig et al., 2009), Ppap2b (LPP3) knockouts are
embryonic lethal due to abnormal development of the vasculature
(Escalante-Alcalde et al., 2003). This may indicate the need for self-
generated LPA gradients in development; elsewhere, self-generated
S1P gradients have been shown to be essential for T-cell function in
the lymph system (Thangada et al., 2010). We also found that
knockdown of LPP1 and LPP2 did not have any overt effect on LPA
degradation, while LPP3 knockdown resulted in initially increased
levels of LPA and slower rates of breakdown over time. Thus, LPP3
appears to be the dominant lipid phosphatase required for LPA
breakdown by melanoma cells.
LPP3 is responsible for melanoma-mediated self-generated
gradients
As there are no reagents currently available to directly visualize LPA
degradation, we have developed a robust assay that can be used to
examine and quantify cell responses to the formation of localized
Fig. 5. LPP3 knockdown inhibits melanoma cell invasion in 2D. (A) (i) Quantification of invasion of WM1158 metastatic melanoma cells transfected with
either a scrambled control siRNA or siRNA targeting LPP3 (LPP3 siRNA 1) in a CIA; mean+s.e.m. shown (n=4 independent experiments, **P<0.01, Student’s
t-test); (ii) representative images of cell invasion at 0 and 24 h. (B) (i) Quantification of invasion of WM1158 cells treated with DMSO control or 10 μM
Ki16425 in a CIA (n=3 independent experiments, ***P<0.0001, Student’s t-test); (ii) representative images of cell invasion at 0 and 24 h. (C) (i) Circular invasion
assay usingWM1158 cells treated with DMSO control or 500 nM HA130 (n=3 independent experiments); (ii) representative images of cell invasion at 0 and 24 h.
3462
RESEARCH ARTICLE Journal of Cell Science (2017) 130, 3455-3466 doi:10.1242/jcs.207514
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
self-generated gradients. We have shown that after ∼6 h, melanoma
cells in uniform serum-containing medium migrate towards the
nearest LPA source. This effect is lost in serum-free medium,
indicating that it is not merely an effect of random migration. Most
importantly, LPP3 knockdown also abolished this effect,
establishing the link between LPA breakdown and the ability of
melanoma cells to form gradients in uniform serum. Although LPP3
is also capable of breaking down the bioactive lipid S1P, it is
unlikely that S1P is involved in these self-generated gradients
as the specific LPA receptor antagonist Ki16425 fully blocked
chemotaxis.
There is substantial literature implicating the phosphodiesterase
autotaxin, which generates LPA from LPC, in cancer spread and
chemotaxis (Nam et al., 2000; Saunders et al., 2008). However, self-
generated chemoattractant gradients generated by autotaxin would
be expected to be high where cells were most dense (at the centre of
tumours), and therefore oppose cancer cell spreading and invasion.
We have shown that in contrast to LPP3 knockdown, the addition of
the autotaxin inhibitor HA130 does not abolish the divergent
chemotaxis of melanoma cells in our assay; in fact the effect
is slightly enhanced. This may be due to the elimination of a
background level of LPA production, which could blur the effect of
the self-generated gradient. Thus, these data confirm that it is the
breakdown of LPA and formation of self-generated gradients that is
the key factor responsible for driving melanoma cell migration,
rather than autotaxin-mediated LPA production. As LPA has a split
role – as well as being a chemoattractant, it is an exceptionally
potent mitogen – it seems more likely that autotaxin’s principal role
is to promote tumour growth. Breakdown of attractants, like the
LPP3-mediated process we have described, generates gradients that
lead away from the tumour and is a more likely driver of metastasis.
A role for LPP3 in melanoma metastasis
Although chemotaxis assays are useful for determining cellular
responses to chemoattractants in 2D (Insall and Andrew, 2007), they
do not emulate the tissue environment faced by tumour cells when
metastasizing. Here, we have used CIAs and 3D spheroid invasion
assays to examine melanoma cells invading a matrix-filled
environment. Although the serum-containing medium in a CIA/
spheroid assay is not flow-restricted as in an Insall chamber, the LPA
may be broken down locally within the Matrigel component
containing the cells, enabling self-generated LPA gradients to be
Fig. 6. LPP3 knockdown inhibits melanoma cell invasion in 3D. 3D spheroid invasion assay using WM852 metastatic melanoma cells either left untreated or
transfected with either a scrambled control siRNA or LPP3 siRNA 1. (A) Representative images of spheroid invasion over 6 days following the addition of
invasion matrix. (B) Quantification of 3D invasion relative to spheroid size on day 1. Means+s.e.m. are shown (n=4 independent experiments, **P<0.01;
***P<0.001, two-way ANOVA). (C) qPCR of LPP3 expression inWM852 at days 0, 3 and 5/6 following addition of invasion matrix (n=3 independent experiments).
(D) Quantification of spheroid size relative to spheroids on day 1, in the absence of any invasion matrix (n=3 independent experiments).
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maintained. Indeed, we found that LPP3 knockdown significantly
inhibited LPA-dependent melanoma cell invasion, reinforcing the role
of self-generated LPA gradients in facilitating melanoma metastasis.
Thus far, we have not found evidence of LPP3 having significantly
altered expression in metastatic melanoma cell lines compared with
non-metastatic melanoma cells. Rather, we hypothesize that upon
tumourigenesis and proliferation of the melanoma cells, the localized
increase in melanoma cell numbers (relating directly to the tumour
thickness, known to pathologists as the ‘Breslow thickness’ and a key
diagnostic) is sufficient to induce the LPP3-mediated degradation of
surrounding LPA above background levels.
These findings present an interesting potential target for anti-
metastatic therapy when treating melanoma. Interestingly, LPP1 and
LPP3 have been targeted in potential therapies for ovarian cancer
(Tanyi et al., 2003b; Benesch et al., 2016). However, these therapies
aimed to increase LPP expression in order to reduce overall LPA
levels, thereby diminishing its pro-tumourigenic effects. In contrast,
we would hypothesize that increasing LPP3 expression in
melanoma cells would speed up their ability to create self-
generated gradients, and thus accelerate migration out of the
tumour. Thus, to diminish metastasis, LPP3 could potentially be
neutralized to inhibit LPA breakdown around a tumour site.
In future, it will be interesting to test the universality of self-
generated gradients in other processes and systems. LPP3 has
previously been shown to be essential in depleting S1P within the
thymus and spleen, setting up S1P gradients that stimulate
lymphocyte migration, while its homologue has been shown to be
involved in germ cell migration in Drosophila (Renault et al., 2004;
Breart et al., 2011; Ramon-Perez et al., 2015). Thus, signalling lipid
breakdown to form self-generated gradients may be common in both
normal physiology and metastasis of various types of cancer,
warranting further investigation into this simple yet powerful
mechanism of cell steering.
MATERIALS AND METHODS
Cell lines and reagents
WM239A, WM1158 and WM852 melanoma cell lines were obtained from
the Wellcome Trust Functional Genomics Cell Bank (Biomedical Sciences
Research Centre, St George’s, University of London, UK). Cells were
cultured in RPMI medium (Invitrogen) supplemented with 2 mM
L-glutamine (Gibco) and 10% fetal bovine serum (FBS; PAA
Laboratories) and confirmed mycoplasma free.
1-Oleoyl-2-hydroxy-sn-glycero-3-phosphate (18:1) and 1-arachidonoyl-
2-hydroxy-sn-glycero-3-phosphate (20:4) LPA was obtained from Avanti.
FlexiTube GeneSolution sets of four siRNAs (Qiagen) were used to target
LPP1, LPP2 and LPP3. LPP3 siRNA 1 was oligo 6 from the ON-TARGET
plus siRNA range (J-017312-06-0005; GE Dharmacon; siRNA sequence:
GGGACUGUCUCGCGUAUCA), LPP3 siRNA 2 was oligo 7 from the
FlexiTube siRNA range (SI03043761, Qiagen; siRNA sequence:
AGCGATCGTCCCGGAGAGCAA), scrambled non-targeting siRNA
control was AllStars negative control siRNA (Qiagen). Ki16425
(Cambridge Bioscience) was used at a final concentration of 10 μM.
HA130 (Echelon Biosciences) was used at a final concentration of 500 nM.
Insall chamber chemotaxis assay
Cells were plated onto fibronectin-coated glass coverslips at a density of
7×104 cells/ml and then serum-starved overnight in serum-free RPMI
medium prior to use as previously described (Muinonen-Martin et al., 2013;
Susanto et al., 2016). Serum-free (SF) medium consisted of RPMI with
2 mM L-glutamine, penicillin/streptomycin (Invitrogen) and 0.5% BSA
(Sigma), while serum-containing medium contained an additional 10%
FBS. LPA-containing medium consisted of SF medium with LPA at the
indicated final concentrations.
Insall chambers were imaged on a Nikon TE2000-E inverted time lapse
microscope equipped with MetaMorph (Molecular Devices), a motorized
stage (Prior Scientific, Cambridge, UK) and Perfect Focus System enclosed
in a plexiglass box humidified and heated to 37°C with 5% CO2. Each
viewing bridge on the Insall chamber was imaged with a 10× objective every
30 min over 24 h.
Cells were manually tracked using the MTrackJ plugin for ImageJ (http://
rsb.info.nih.gov/ij). All cells on the bridge at the beginning of the
experiment were tracked, excluding cells that died, to the end of the
experiment or until the cells moved off the viewing bridge. Chemotactic
index was calculated as described (Muinonen-Martin et al., 2014).
siRNA knockdown
Cells were transfected with scrambled or gene-targeting siRNA using
Lullaby transfection reagent (Oz Biosciences). Cells were transfected twice
with 25 nM siRNA, once every 48 h, then assayed 48 h after the second
transfection.
To assess gene knockdown, RNA was extracted from cells using an
RNeasy mini kit (Qiagen) and cDNA synthesized from 0.5 μg samples
using a SuperScript III reverse transcriptase kit (Life Technologies) as
specified by the manufacturer. qPCR was performed using PerfeCTa SYBR
green FastMix (Quanta), with cDNA analysed in triplicate using a 7500 fast
real-time PCR system (Applied Biosciences); data were extracted using
Applied Biosystems 7500 software version 2.0. QuantiTect primer kits
(Qiagen) were used to assess gene expression of GAPDH, PPAP2A/LPP1,
PPAP2B/LPP3 and PPAP2C/LPP2, with all gene expression normalized
against GAPDH as an internal control using the comparative Ct method
(Schmittgen and Livak, 2008).
Mass spectrometry
Cells were plated in a 6-well dish at a density of 1×105 per well, then treated
with siRNA. Twenty-four hours after the final transfection of siRNA, old
medium was removed and 2 ml of fresh LPA or serum-containing RPMI
was added to each well. Media used for LPP knockdown experiments after
24 h was serum-free RPMI with 10 µM 18:0, 18:1 and 20:4 LPA added.
Media used for LPP3 knockdown time course experiments was RPMI with
10% serum. One millilitre of supernatant was collected at the indicated time
points and a standard amount of synthetic 17:0 LPAwas added to the sample
prior to butanol extraction (Muinonen-Martin et al., 2014). LPA was
analysed using a QExactive orbitrap coupled to a Dionex UltiMate 3000 LC
system (Thermo Scientific). The LC parameters were as follows: 4 µl of
sample was injected onto a 1.7 µm particle 100×2.1 mm ID Waters
ACQUITY CSH C18 column, which was kept at 50°C throughout the
analysis. A gradient system of (A) aqueous 0.05% ammonium hydroxide
and (B) 0.05% ammonium hydroxide/methanol was used, with a linear
gradient of 0.3 ml/min from 50 to 90%B over 7 min rising to 100%Bwithin
1 min and maintaned for 2 min. Thereafter, the column was returned to
initial conditions and equilibrated for another 4 min. Lysophospholipids
were analysed in electrospray negative ionization mode, with spray voltage
3 kV, capillary temperature 300°C, sheath gas flow rate 50, and auxiliary gas
flow rate 10. The resolution was set to 70,000, automatic gain control was set
to 1×106 with a maximum injection time of 200 ms and the scan range was
300–700 m/z. Peak areas were determined using MAVEN (Melamud et al.,
2010; Clasquin et al., 2012) and concentrations were normalized to the LPA
(17:0) standard.
Circular invasion assay
The CIAwas carried out as previously described (Yu andMachesky, 2012;
Susanto et al., 2016). Briefly, an Ibidi culture insert was adhered to the
centre of a 35 mm low μ-dish (Ibidi), then 1×106 WM1158 cells were
plated in the dish around the insert. The following day the insert and
supernatant medium were removed and 200 μl of Matrigel (Corning)
diluted 1:1 with chilled PBS was added and left to set for 1 h at 37°C; 1 ml
serum-containing medium was then added to the dish prior to imaging. If
treated with DMSO, Ki16425 or HA130, cells were incubated for 15 min
in medium containing the inhibitor/vehicle before removing the culture
insert. DMSO/Ki16425/HA130 was also added to the Matrigel and
medium added prior to imaging. The level of invasion after 24 h was
determined using ImageJ and calculated relative to the scrambled/DMSO
treated controls.
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Spheroid invasion assay
WM852 cells were treated with siRNA as described above, then harvested
24 h after the second hit of siRNA. The spheroid invasion assay was
performed as per instructions using a Cultrex 96-well 3D Spheroid BME
Cell Invasion Assay kit (Trevigen). Briefly, cells were resuspended in the
Spheroid Formation Extracellular Matrix and 1×103 cells were plated per
well (in triplicate minimum per condition). The cells were left to form
spheroids for 3 days, then Invasion Matrix was added to the invasion
condition wells and culture medium was added to the control wells.
Spheroids were imaged each day for 6 days following addition of the
invasion matrix, using a brightfield microscope. Relative invasion was
analysed using ImageJ by thresholding the spheroid area and measuring the
number of pixels within that area. Each measurement per day was divided by
the measurement taken on day 1 (following addition of the invasion matrix)
and calculated as a percentage of spheroid area on day 1.
Chemotaxis simulation model
The agent-based model, modified from Tweedy et al. (2016a), simulated
cells locally degrading a freely diffusing chemoattractant. Diffusion was
simulated explicitly on a grid using a central differences approximation to
the diffusion equation. The wells were modelled as large, finite and well-
mixed reservoirs in contact with the grid. Cell movement was biased by the
receptor occupancy difference across the cell, with receptor occupancy at a
point x given by θ=c(x)/[c(x)+Kd].
Statistics
All graphs (excluding spider and rose plots) and statistics (excluding
Rayleigh tests) were generated using GraphPad Prism 6. Spider plots were
generated using Microsoft Excel. Rose plots were generated using the
‘circular’ package in R. Circular confidence intervals were denoted in red,
and were calculated using the approach outlined by Upton and Fingleton
(Upton and Fingleton, 1989). The P-values for the circular range test were
calculated using the formula stated in Mardia and Jupp (Mardia and Jupp,
1999), and the P-values for the Rayleigh test were calculated using the
method outlined in Mardia and Jupp (Mardia and Jupp, 1999).
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